Chaoyang Mississippi Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Chaoyang Mississippi Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HYNESAFE. The owner is based in Chaoyang, Liaonin.

Room 603, Unit 4, Building 51, Section 3

Youyi Street, Shuangta District

Chaoyang, Liaonin 122000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HYNESAFE
HYNESAFE
Registered 2022

Trademark Classifications

Chaoyang Mississippi Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Chaoyang Mississippi Technology Co., Ltd. have?

Chaoyang Mississippi Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Chaoyang Mississippi Technology Co., Ltd. file in?

Chaoyang Mississippi Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Chaoyang Mississippi Technology Co., Ltd.'s most well-known trademarks?

Chaoyang Mississippi Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as HYNESAFE. These are among 1 currently registered trademark in the portfolio.

What is Chaoyang Mississippi Technology Co., Ltd.'s trademark registration success rate?

Chaoyang Mississippi Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.